Panzer S, Kaplan C
Clinic for Blood Group Serology, University of Vienna, Austria.
Transfus Med. 1998 Jun;8(2):125-8. doi: 10.1046/j.1365-3148.1998.00137.x.
The results from the 1997 International human platelet antigen- (HPA-) genotyping workshop are reported. Seventeen institutions participated to genotype for HPA polymorphisms of seven DNA samples. Most investigators used the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and PCR-sequence specific priming (SSP). A few participants applied both methods to confirm their results. All participants reported results for HPA-1, -2, -3 and -5 allotyping, while HPA-4 was determined in 12 and HPA-6 in nine laboratories, respectively. For HPA-1 to -6 there were 19 deviations from the consensus result. These deviations were not associated with any particular technique or allotype. Most frequently, however, deviation were reported for HPA-5 typing. These results were discussed at a meeting at the Joint Congress of the ISBT and the Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie in Frankfurt, Germany, in September 1997. Based on the results and the comments, further workshops for HPA-allotyping are mandatory for quality assurance.
本文报告了1997年国际人类血小板抗原(HPA)基因分型研讨会的结果。17个机构参与了对7个DNA样本的HPA多态性进行基因分型。大多数研究者采用聚合酶链反应(PCR)-限制性片段长度多态性(RFLP)和PCR-序列特异性引物(SSP)方法。少数参与者同时应用这两种方法来确认结果。所有参与者都报告了HPA-1、-2、-3和-5分型结果,而分别有12个实验室测定了HPA-4,9个实验室测定了HPA-6。对于HPA-1至-6,共有19个结果与共识结果存在偏差。这些偏差与任何特定技术或血型无关。然而,最常报告的偏差是HPA-5分型。1997年9月在德国法兰克福举行的国际输血协会(ISBT)和德国输血医学与免疫血液学协会联合大会的一次会议上讨论了这些结果。基于这些结果和评论,为确保质量,必须进一步举办HPA分型研讨会。